Insider Transactions in Q2 2023 at Nova Bay Pharmaceuticals, Inc. (NBY)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 11
2023
|
Yongxiang Zheng Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+50.0%
|
-
|
|
May 11
2023
|
Julie Garlikov Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+50.0%
|
-
|
|
May 11
2023
|
Swan Sit Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+33.33%
|
-
|
|
May 11
2023
|
Mijia Wu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+33.33%
|
-
|
|
May 11
2023
|
Yenyou Zheng Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+33.33%
|
-
|
|
May 11
2023
|
Paul E. Freiman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+33.33%
|
-
|